Company
Headquarters: Beijing, China
Employees: 951
HK$5.08 Billion
HKD as of July 1, 2024
US$649.9 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $178.02 B |
| Stryker Corporation | $126.48 B |
| Boston Scientific Corporation | $112.32 B |
| Medtronic | $98.95 B |
| Edwards Lifesciences Corporation | $55.63 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. The company offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. It primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. The company also exports its products to 38 countries and regions in Asia, South America, Africa, Oceania, and Europe. Beijing Chunlizhengda Medical Instruments Co., Ltd. was incorporated in 1998 and is headquartered in Beijing, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Beijing Chunlizhengda Medical Instruments Co. Ltd has the following listings and related stock indices.
Stock: HKEX: 1858 wb_incandescent